Cardax Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
35.30
610.30
1,510.90
Cost of Goods Sold (COGS) incl. D&A
36.20
39.00
23.80
43.70
304.10
2,972.60
Gross Income
36.20
39.00
23.80
8.40
306.20
1,461.80
SG&A Expense
3,555.50
16,843.00
3,418.80
1,821.80
2,325.70
2,560.70
EBIT
3,591.70
16,882.00
4,401.10
1,830.20
2,019.50
4,022.50
Non Operating Income/Expense
27.50
2.40
143.20
44.20
3.50
3.70
Interest Expense
741.90
118.80
2.30
-
-
-
Pretax Income
4,361.20
16,994.60
4,257.90
1,783.70
2,019.70
4,024.20
Income Tax
-
-
-
-
34.50
-
Consolidated Net Income
4,361.20
16,994.60
4,257.90
1,783.70
1,985.20
4,024.20
Net Income
4,361.20
16,994.60
4,257.90
1,783.70
1,985.20
4,024.20
Net Income After Extraordinaries
4,361.20
16,994.60
4,257.90
1,783.70
1,985.20
4,024.20
Net Income Available to Common
4,361.20
16,994.60
4,257.90
1,783.70
1,985.20
4,024.20
EPS (Basic)
0.46
0.28
0.06
0.02
0.02
0.03
Basic Shares Outstanding
9,488.20
60,225.50
66,873.80
76,227.50
99,951.40
127,304.90
EPS (Diluted)
0.46
0.28
0.06
0.02
0.02
0.03
Diluted Shares Outstanding
9,488.20
60,225.50
66,873.80
76,227.50
99,951.40
127,304.90
EBITDA
3,555.50
16,843.00
4,377.30
1,801.10
1,990.10
3,991.90
Other Operating Expense
-
-
958.60
-
-
-
Non-Operating Interest Income
-
3.70
2.40
2.40
3.30
1.90

About Cardax

View Profile
Address
2800 Woodlawn Drive
Honolulu Hawaii 96822
United States
Employees -
Website http://www.cardaxpharma.com
Updated 07/08/2019
Cardax, Inc. is a life sciences company, which engages in the development, marketing, and distribution of consumer health products. It focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI.